Feldman Heart Failure

Device Management
1. Auflage 2009
ISBN: 978-1-4443-1443-4
Verlag: John Wiley & Sons
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 200 Seiten, E-Book

When you're considering device therapy for a patient with heartfailure, be sure to consult this concise reference for the latestinformation on who benefits most from which device.
In clear, straightforward prose, Dr. Feldman addresses:
* Resynchronization Therapy
* ICD
* Ultrafiltration
* Impulse Therapy
* Chronic Implantable Monitoring
* Bioimpedance
* EECP
* and more
With chapters devoted to monitoring the patient on devicetherapy and the future of device therapy in heart failure, thisbook makes an important contribution to patient care.

Autoren/Hrsg.

Feldman, Arthur

Inhaltsverzeichnis

Contributor list.
Preface.
Chapter One: Cardiac Resynchronization Therapy (Behzad Pavriand Arthur M. Feldman).
Chapter Two: Implantable Cardioverter-Defibrillator Therapy(Reginald T. Ho and Arnold J.Greenspon).
Chapter Three: Chronic Implantable Monitoring (Nisha Aggarwaland David J. Whellan).
Chapter Four: Cardiac Contractility Modulation by ElectricalSignals Applied During Absolute Refractory Period as a Treatmentfor Chronic Heart Failure (Daniel Burkhoff, Hani N. Sabbah,Christian Butter, Yuval Mika and Martin Borggrefe).
Chapter Five: Role of Cardiac Restraint Devices in the Treatmentof Patients with Dilated Cardiomyopathy (Douglas L.Mann).
Chapter Six: The Role of Right Heart Catherization in Managementof Patients with Heart Failure (Sandeep A. Kamath and Mark H.Drazner).
Chapter Seven: Impedance Cardiography (Sunthosh V.Parvathaneni and Ileana L. Pina).
Chapter Eight: The Use of Echocardiography in Evaluating theHeart Failure Patient and Response to Therapy (John GorscanIII).
Chapter Nine: Revascularization for Left Ventricular Dysfunction(Nicholas J. Ruggiero II, Thomas J. Kiernan, Juan M. Bernal andIgor F. Palacios).
Chapter Ten: Minimally Invasive Treatment of Mitral ValveDisease (Andra Popescu and Paul J. Mather).
Chapter Eleven: Percutaneous Mechanical Assist Devices(Suresh Mulukutla, Lawrence Schneider and Howard A.Cohen).
Chapter Twelve: Left Ventricular Assist Devices for Acute andChronic Heart Failure (Daniel Marelli, Louis Stein, AbbasArdehali).
Chapter Thirteen: The Role of Enhanced External Counterpulsation(EECP) in Heart Failure Management (Marc A. Silver and WilliamE. Lawson).
Chapter Fourteen: Ultrafiltration (Maria RosaConstanzo).
Conclusion.
Index.
Conflict of Interest Table.

Über Autor(innen)

Arthur M Feldman MD PhD
After receiving his B.A. degree from Gettysburg College, andM.S. and Ph.D. degrees from the University of Maryland, Dr. Feldmanserved as a post-doctoral fellow in physiology at the Johns HopkinsUniversity School of Medicine. After completing his medical degreeat the Louisiana State University School of Medicine, he returnedto Johns Hopkins where he served as an intern, resident andcardiology fellow.
After joining the faculty in 1985, he was named the Director of theBelfer Laboratory for Molecular Biology of Heart Failure and theDirector of the Heart Failure Research Program at The Johns HopkinsUniversity School of Medicine. In 2004 Dr. Feldman joined thefaculty at the University of Pittsburgh School of Medicine as theHarry S. Tack Professor of Medicine, Chief of the Division ofCardiology, and Director of the Cardiovascular Institute of theUPMC Health System.
In 2002, Dr. Feldman was named the Magee Professor of Medicine andChairman of the Department of Medicine at Jefferson MedicalCollege. He is a past President of the Heart Failure Society ofAmerica and of the Association of Professors of Cardiology. He hasserved on the editorial boards of many scientific journals and waselected to membership in organizations including Alpha Omega Alpha,the Association of University Cardiologists, the American Societyfor Clinical Investigation and the Association of AmericanPhysicians.
He has published over 200 peer-reviewed articles. Dr. Feldman'sresearch has focused on molecular and clinical aspects of heartfailure. Most recently he has chaired the Steering Committees forthe PEECH, EMOTE and WEAR-IT trials and co-chaired the COMPANIONstudy.